Patents

  1. Vaccine with reduced enhancement of viral infection
    US20170312354A1
  2. Prediction of unknown biological function of the active site in proteins or/and polynucleotides, and its utilization
    US20020098519A1
  3. Method of designing physiologically active peptide and use thereof
    CA2497477A1
  4. Normalization controls for managing low sample inputs in next generation sequencing
    EP3861135A1
  5. Universal influenza vaccine targeting virus/host recognition
    US20190351046A1
  6. Method of non-linear analysis of biological sequence data
    US6728642B2
  7. Peptide agonists of toll-like receptor 5 ligand and method of use
    US20170051021A1
  8. Method and electronic system for predicting at least one fitness value of a protein via an extended numerical sequence, related computer program product
    US20210265014A1
  9. Method of designing bioactive peptide and use thereof
    US7660677
  10. Analogous peptides of the internal image of a viral protein
    EP0728203A1
  11. Polypeptides mimicking the activity of human erythropoietin
    CA2258871A1
  12. Peptides which react with antibody representing the prognostic marker for HIV disease progression
    US20010007017A1
  13. Polypeptide immunologically cross-reactive with NTM peptide and with vasoactive intestinal peptide
    GB2313376A
  14. Vaccine with reduced enhancement of viral infection
    US10322171
  15. Peptides immunologically related to known viral protein
    US6294174
  16. Compositions and methods for flavivirus vaccination
    US10835596
  17. Computer aided drug resistance calculator calculating drug resistance using amprenavir as a case study
    US20150370964